From our set of 19 ORs, due to the scarcity of RNA from patients’ diagnostic samples, we randomly selected nine genes and investigated their expression levels in a different subset of bone marrow or peripheral blood from AML patients and healthy donors: OR52H1, OR52B6, OR13D1, OR2AK2, OR2L5, OR5C1, OR2G2, OR13F1 and OR1L6, plus the nonexpression control OR4x2. This evidence concerns the gene OR2G2 and acute myeloid leukemia.